Sign in
Enrolling by invitationNo phase

Computer score from heart ultrasound to predict risk in aortic stenosis

Tests a computer-based score for judging risk in older adults with mild aortic stenosis.

Key facts

Who runs it
Yale University
Where
Houston, New Haven, and New York, United StatesSee the 3 sites
Trial code
Registry title
Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study
Status
Enrolling by invitation
People taking part
210 people, planned
Started
6 May 2026
Expected to end
31 Aug 2028
Type of study
Observational
Treatments tested
  • Transthoracic echocardiogram
Record updated
8 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 65 or older with aortic sclerosis or mild aortic stenosis, a stiffening or narrowing of the heart's main valve. It tests a digital score for predicting risk.

Age
65 years or older
Sex
All sexes can join
Disease stage
Aortic sclerosis without narrowing, or mild aortic stenosis, seen on a heart ultrasound (transthoracic echocardiogram) in the past 2-3 years
Earlier treatment
People who have had their aortic valve replaced or repaired, by catheter or surgery, cannot join.

Main reasons for not taking part

  • Any echocardiogram within 24 months of the medical record review
  • Implanted heart device, such as a pacemaker, defibrillator or left ventricular assist device
  • Prior heart transplant or history of dementia
  • Life expectancy of <1 year, or currently in hospice care
  • Does not speak English, or cannot attend the study visit at the echocardiogram lab within four years of the last echocardiogram

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age 65 years or older
  • Prior transthoracic echocardiogram within the past 2-3 years showing aortic sclerosis without stenosis or mild AS

Who cannot take part

  • Prior history of aortic valve replacement or repair, including transcatheter and surgical AVR with either a bioprosthetic or mechanical valve
  • Prior heart transplant
  • Presence of implantable cardiac devices, including permanent cardiac pacer, implantable cardioverter-defibrillator, or left ventricular assist device
  • History of dementia
  • Opted out of research studies
  • Non-English speaking
  • Any echocardiogram within 24 months of medical record review
  • Unable to attend study visit at echocardiogram lab within four years of most recent echocardiogram
  • Documented life expectancy of <1 year or current participation in hospice services

Where in United States

  • The Methodist Hospital Research InstituteHouston, United StatesEnrolling by invitation
  • Yale-New Haven Health SystemNew Haven, United StatesEnrolling by invitation
  • Icahn School of Medicine at Mount SinaiNew York, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This study will evaluate the validity of a digital biomarker score for precision risk stratification among older adults with aortic sclerosis or mild aortic stenosis (AS) at three US health systems.

Treatments tested

  • Transthoracic echocardiogram

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study
Plain-language title
Computer score from heart ultrasound to predict risk in aortic stenosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
8 May 2026